FSD Pharma Inc. goes public, progresses with business plan

The cannabis company is focused on building the world’s largest indoor hydroponic cultivation and processing facility
FSD Pharma Inc. goes public, progresses with business plan
The company continues to build out its state-of-the-art hydroponic cultivation and processing facility in Cobourg, Ontario

FSD Pharma (CSE:HUGE) announced today that it has started trading publicly on the Canadian Securities Exchange (CSE), as well as continuing to cultivate its business through financing, licensing, investing and operational goals.

“Today marks an exciting achievement for us to become a publicly traded on the CSE…” said Thomas Fairfull, president and chief executive officers of FSD. “The Canadian cannabis industry is developing with pace and we believe quality cannabis will be the backbone of all our future cannabis, cannabis products, ancillary business and pharmaceutical development initiatives.”

The company says it is committed to cultivating the highest quality cannabis at scale through building out its state-of-the-art hydroponic cultivation and processing facility in Cobourg, Ontario – the world’s largest.

“Going forward, we will continue to aggressively pursue our business plan and update our shareholder community in an ultimate effort to deliver significant shareholder value,” said Fairfull.

Other highlights

FSD Pharma has also been busy checking a number of items off its list, including these highlights:

  • The company closed on the purchase of the former KRAFT food manufacturing facility in Cobourg, Ontario, which is owned with no debt. The facility is an existing 620,000 sq/ft indoor facility sitting on a 70 acre parcel of land.

  • It has raised $53,000,000 of equity capital to date, led exclusively by First Republic Capital

  • In October 2017, FSD Pharma’s wholly owned subsidiary FV Pharma Inc. obtained its ACMPR license to cultivate as a federally licensed producer

  • It developed a strategic partnership with Cannabis Wheaton Income Corp. (CVE:CBW). Wheaton will develop the company’s cultivation facility (receiving 49.9% of all cannabis and cannabis related production from the facility) and it is anticipated that at full capacity, 200,000,000 grams of dried cannabis flower will be received by FV Pharma annually.

Shares of FSD Pharma were at C$0.13 on Tuesday.

View full HUGE profile View Profile

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You understand that the Company receives either monetary or securities compensation for our services. We stand to benefit from any volume this write-up may generate.

You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Copyright © 2ndrangers.us, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated.